HTG Molecular Diagnostics (STU:65H) Other Long-Term Liabilities : €3.18 Mil (As of Mar. 2023)

View and export this data going back to 2017. Start your Free Trial

What is HTG Molecular Diagnostics Other Long-Term Liabilities?

HTG Molecular Diagnostics's other long-term liabilities for the quarter that ended in Mar. 2023 was €3.18 Mil.

HTG Molecular Diagnostics's quarterly other long-term liabilities declined from Sep. 2022 (€3.70 Mil) to Dec. 2022 (€3.37 Mil) and declined from Dec. 2022 (€3.37 Mil) to Mar. 2023 (€3.18 Mil).

HTG Molecular Diagnostics's annual other long-term liabilities declined from Dec. 2020 (€3.73 Mil) to Dec. 2021 (€3.53 Mil) and declined from Dec. 2021 (€3.53 Mil) to Dec. 2022 (€3.37 Mil).

HTG Molecular Diagnostics Other Long-Term Liabilities Historical Data

The historical data trend for HTG Molecular Diagnostics's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HTG Molecular Diagnostics Other Long-Term Liabilities Chart

HTG Molecular Diagnostics Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Other Long-Term Liabilities

Get a 7-Day Free Trial

HTG Molecular Diagnostics Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
Other Long-Term Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

HTG Molecular Diagnostics Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

HTG Molecular Diagnostics Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of HTG Molecular Diagnostics's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

HTG Molecular Diagnostics (STU:65H) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » HTG Molecular Diagnostics Inc (STU:65H) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

HTGMQ:USA

Address

3430 E. Global Loop, Tucson, AZ, USA, 85706

Website

https://www.htgmolecular.com

HTG Molecular Diagnostics Inc is a commercial-stage RNA platform-based life sciences company focused on advancing the promise of precision medicine. Its proprietary NGS-adapted chemistry and HTG EdgeSeq platform automates sample processing and can quickly, robustly, and simultaneously profile hundreds or thousands of molecular targets using a relatively small amount of biological samples, in liquid or solid forms. Its products include instruments, consumables, and software that combine to form its HTG EdgeSeq platform. The company's menu of HTG EdgeSeq molecular profiling panels is automated on its HTG EdgeSeq platform, applying genomic sequencing tools to quickly generate gene expression data using its simplified workflow for customers.

HTG Molecular Diagnostics (STU:65H) Headlines

No Headlines